Article by Sam Riches, Growth Op
Researchers at the University of California San Diego are launching a new placebo-controlled study to determine how cannabis affects migraines.
Dr. Nathaniel Schuster, lead researcher on the project, told KGTV that it is the first known randomized, double-blind, placebo-controlled clinical trial looking at cannabis as a potentially effective treatment for acute migraines.
“We want to know whether it is more effective than placebo, whether it is beneficial for the headache part of migraine, whether it’s helpful for the other parts of migraine,” Schuster said.
Getting the necessary approvals for the study took several years, he said, noting that the government will be supplying the medical-grade cannabis.
Study participants will use an app to track the effects of four different doses on four separate headaches. Using a vaporizer, participants will not know whether they are inhaling THC, CBD, a combination of the two or a placebo.
According to a release from UC San Diego, the goal is to enroll 90 participants in the study.
Allison Knigge, an elementary school teacher, has already signed up.